In the Media
Are you looking for the latest media coverage of the BioMed X Institute, its research projects and people behind the innovation model? Here you will find the latest clippings – hot off the press!
Visit: How to create an Innovation Honeypot
How to create an Innovation Honeypot
Startup City
Human talent is spread evenly across the globe. Opportunity is not. This has always been the case. But was has changed recently is the advent of global mobility.
Visit: 15 Most Promising Biotech Startups in Europe – 2019
15 Most Promising Biotech Startups in Europe – 2019
Startup City
As new technologies emerge, numerous biotech startups are launched across Europe every year. With specialized venture capital firms and technology companies pouring money into the sector, biotech startups now attract record amount of investment.
Visit: R&D MEETS THE CROWDSCAPE: BioMed X looks outsight for insight
R&D MEETS THE CROWDSCAPE: BioMed X looks outsight for insight
In Vivo
Germany’s BioMed X “outcubator” is investing in the wisdom of the science crowd to redeploy the cognitive division of labor in preclinical research.
Visit: How researchers are ensuring that their work has an impact
How researchers are ensuring that their work has an impact
nature
When Melissa Craig realized that biological matter such as algae might slow the speed of powerful underwater landslides by releasing chemicals that help to glue sea-floor mounds together, she failed to share her colleagues’ enthusiasm around the discovery.
Visit: Establishing a reliable framework for harnessing the creative power of the scientific crowd
Establishing a reliable framework for harnessing the creative power of the scientific crowd
PLOS BIOLOGY
Discovering new medicines is difficult and increasingly expensive. The pharmaceutical industry has responded to this challenge by embracing open innovation to access external ideas.
Visit: Challenges: Crowdsourced solutions
Challenges: Crowdsourced solutions
nature
Open competitions bring new minds, skills and collaborations to problems in biomedical research.
Visit: BioMed X emerges from Merck KGaA alliance armed with bioinformatics tools
BioMed X emerges from Merck KGaA alliance armed with bioinformatics tools
fiercebiotech.com
BioMed X has begun offering bioinformatics services on the back of its alliance with Merck KGaA. The services are underpinned by tools developed during BioMed X’s three-year collaboration with Merck KGaA, during which it advanced computational approaches to the design of highly selective kinase inhibitors.
Visit: Fischen im Schwarm
Fischen im Schwarm
SĂĽddeutsche Zeitung.de
Die groĂźen Pharmaunternehmen sind immer auf der Suche nach bahnbrechenden Forschungsergebnissen. Einige versuchen jetzt auch, Ideen aus der Crowd umzusetzen und zu Geld zu machen.